Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios Pro Rata

Dive into the world of dealmakers across VC, PE and M&A with Axios Pro Rata. Delivered daily to your inbox by Dan Primack and Kia Kokalitcheva.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Austin news?

Get a daily digest of the most important stories affecting your hometown with the Axios Austin newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Atlanta news?

Get a daily digest of the most important stories affecting your hometown with the Axios Atlanta newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Philadelphia news?

Get a daily digest of the most important stories affecting your hometown with the Axios Philadelphia newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Chicago news?

Get a daily digest of the most important stories affecting your hometown with the Axios Chicago newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Prime Minister Jacinda Ardern and Director-General of Health Ashley Bloomfield announce that the quarantine free travel arrangement with Australia will be suspended for eight weeks. Photo: Hannah Peters/Getty Images

New Zealand Prime Minister Jacinda Ardern announced Friday that quarantine-free travel from Australia to New Zealand will be suspended as COVID-19 cases rise in Australia.

Why it matters: The travel bubble, which opened in April, was supposed to boost the economy and serve as a model to safely allow international travel. More than 200,000 people have utilized the quarantine-free travel bubble since April, the Washington Post reports.

  • The suspension begins Friday and will last for at least eight weeks. The prime minister said that any New Zealanders visiting Australia should return within the next seven days.
  • Only about 12% of Australia’s population is fully vaccinated, according to Johns Hopkins University data.

What they're saying: “Now is the time for a suspension to ensure New Zealanders aren’t put at undue risk from COVID-19 and to ensure we retain our hard won gains," Ardern said in a statement.

  • "Our team of five million has worked hard to put us in a strong position both health-wise and economically. We will not risk that,” Ardern added.

Go deeper

Updated 3 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Vaccines: Fauci: "I would vaccinate them in a second" — CDC says some immunocompromised people can get fourth COVID shot — FDA panel endorses Pfizer vaccines for 5-11 year olds.
  2. Health: COVID cases fall by 20% — Public health messaging lessons for the next pandemic — Common antidepressant guards against COVID hospitalization, study finds — COVID cases, deaths at meat plants were far higher than previously thought.
  3. Politics: NYC firefighters union urges members to defy mayor's vaccine mandate — Judge rejects Southwest pilots' challenge to vaccine mandate — Louisiana lifts mask mandate except for some schools.
  4. Education: Benefits of vaccine for children outweigh risks, FDA says — Education secretary reveals limits to Biden’s mask push on states — LA extends deadline for school employee vaccinations.
  5. Variant tracker: Where different strains are spreading.
Oct 27, 2021 - Health

COVID cases, deaths at meat plants were far higher than previously thought

Tyson Foods in Portland, Maine, in 2020. Photo: Gregory Rec/Portland Press Herald via Getty Images

Cases and deaths from COVID-19 among workers at the five largest U.S. meatpacking companies were nearly three times higher than previously thought, according to a memo from the House panel probing the response to the pandemic.

Driving the news: At least 59,000 workers contracted COVID-19 and 269 workers died at Tyson Foods, JBS USA, Cargill, National Beef and Smithfield Foods — which together make up more than 80% of the beef market and 60% of the pork market in the U.S. — according to counts through January of this year.

16 hours ago - Health

Study: Common antidepressant guards against COVID hospitalization

A COVID-19 intensive care unit in Rio de Janeiro in May. Photo: Fabio Teixeira/Anadolu Agency via Getty Images

The readily available antidepressant fluvoxamine significantly reduced COVID-related hospitalizations, according to a large study published Wednesday.

Why it matters: The clinical trial suggests that a cheap, readily available drug could dramatically reduce serious illness and death when prescribed early.